東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

The Impact of Aging on Antiviral Pathways and Immune Functions.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The Impact of Aging on Antiviral Pathways and Immune Functions./
作者:	Connors, Jennifer Rebecca.
面頁冊數:	1 online resource (292 pages)
附註:	Source: Dissertations Abstracts International, Volume: 83-11, Section: B.
Contained By:	Dissertations Abstracts International83-11B.
標題:	Immunology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29160959click for full text (PQDT)
ISBN:	9798426830882

The Impact of Aging on Antiviral Pathways and Immune Functions.
Connors, Jennifer Rebecca.

The Impact of Aging on Antiviral Pathways and Immune Functions. - 1 online resource (292 pages)

Source: Dissertations Abstracts International, Volume: 83-11, Section: B.

Thesis (Ph.D.)--Drexel University, 2022.

Includes bibliographical references

As global populations shift into higher age demographics there is a significant global public health challenge caused by increased morbidity and mortality associated with age. These aging associated morbidities and mortalities can be partially attributed to a condition of chronically enhanced basal inflammatory levels and immune system dysregulation known as immunosenescence. This phenomenon is suspected to decrease vaccine efficacy and natural immunity against multiple infections including coronavirus disease of 2019 (COVID-19). It is well documented that older individuals have severe COVID-19 complications including pneumonia, respiratory failure, or acute respiratory distress syndrome (ARDS). We have previously demonstrated older donors have delayed and defective induction of type I interferons, T-cell and B-cell helper cytokines in response to TLR/RLR ligands when compared to those from younger adult subjects. However, the underlying intracellular mechanisms defining these defects are not well described. We investigated these impairments in the aging immune system within the context of COVID- 19 vaccination status and COVID-19 infection. We hypothesized that the anti-viral signaling alterations that we observe in healthy older individuals have lasting impacts on how they respond to mRNA vaccination, and SARS-CoV-2 infection. We show that type I IFN production, including the phosphorylation of IRF7 and TBK-1 in the TLR 7/8, RIG-I or cGAS-STING pathways and phagocytosis is dysregulated in innate immune cells (i.e., cDC1s, cDC2s, and CD14dimCD16+ monocytes) from healthy aged individuals (> 65yrs old). Anti-viral signaling deficits are also highlighted after application of lipid nanoparticles that are devoid of mRNA (eLNP). Accordingly, application of eLNP resulted in maturation and activation of monocytes and dendritic cells as well as increased phagocytosis. Germinal center dendritic cells (cDC2) display altered anti-inflammatory capacity characterized by increased frequency of PD-L1 and production of TGF-B2 and TGF-B3 when treated with eLNP, suggesting eLNP-mediated immunomodulation is differential across age groups. These findings have been expanded upon in a COVID-19 cohort to similar affect. Taken together, these studies and results discussed herein highlight the importance of antiviral target identification that is considerate of immunosenescent defects and subsequently will enhance vaccine induced immune responses in > 65 individuals.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798426830882Subjects--Topical Terms:

611031
Immunology.
Subjects--Index Terms:

Anti-viral signalingIndex Terms--Genre/Form:

542853
Electronic books.

The Impact of Aging on Antiviral Pathways and Immune Functions.
LDR:03843nmm a2200385K 4500 001 2363879
005 20231127094722.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798426830882
035 $a (MiAaPQ)AAI29160959
035 $a AAI29160959
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Connors, Jennifer Rebecca. $3 3704654
245 1 4 $a The Impact of Aging on Antiviral Pathways and Immune Functions.
264 0 $c 2022
300 $a 1 online resource (292 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 83-11, Section: B.
500 $a Advisor: Nonnemacher, Michael.
502 $a Thesis (Ph.D.)--Drexel University, 2022.
504 $a Includes bibliographical references
520 $a As global populations shift into higher age demographics there is a significant global public health challenge caused by increased morbidity and mortality associated with age. These aging associated morbidities and mortalities can be partially attributed to a condition of chronically enhanced basal inflammatory levels and immune system dysregulation known as immunosenescence. This phenomenon is suspected to decrease vaccine efficacy and natural immunity against multiple infections including coronavirus disease of 2019 (COVID-19). It is well documented that older individuals have severe COVID-19 complications including pneumonia, respiratory failure, or acute respiratory distress syndrome (ARDS). We have previously demonstrated older donors have delayed and defective induction of type I interferons, T-cell and B-cell helper cytokines in response to TLR/RLR ligands when compared to those from younger adult subjects. However, the underlying intracellular mechanisms defining these defects are not well described. We investigated these impairments in the aging immune system within the context of COVID- 19 vaccination status and COVID-19 infection. We hypothesized that the anti-viral signaling alterations that we observe in healthy older individuals have lasting impacts on how they respond to mRNA vaccination, and SARS-CoV-2 infection. We show that type I IFN production, including the phosphorylation of IRF7 and TBK-1 in the TLR 7/8, RIG-I or cGAS-STING pathways and phagocytosis is dysregulated in innate immune cells (i.e., cDC1s, cDC2s, and CD14dimCD16+ monocytes) from healthy aged individuals (> 65yrs old). Anti-viral signaling deficits are also highlighted after application of lipid nanoparticles that are devoid of mRNA (eLNP). Accordingly, application of eLNP resulted in maturation and activation of monocytes and dendritic cells as well as increased phagocytosis. Germinal center dendritic cells (cDC2) display altered anti-inflammatory capacity characterized by increased frequency of PD-L1 and production of TGF-B2 and TGF-B3 when treated with eLNP, suggesting eLNP-mediated immunomodulation is differential across age groups. These findings have been expanded upon in a COVID-19 cohort to similar affect. Taken together, these studies and results discussed herein highlight the importance of antiviral target identification that is considerate of immunosenescent defects and subsequently will enhance vaccine induced immune responses in > 65 individuals.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Immunology. $3 611031
650 4 $a COVID-19. $3 3554449
653 $a Anti-viral signaling
653 $a Dendritic cell
653 $a Innate immunology
653 $a Lipid nanoparticle mRNA vaccine
653 $a Monocyte
653 $a SARS-CoV-2
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0982
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a Drexel University. $b Microbiology and Immunology (College of Medicine). $3 3562736
773 0 $t Dissertations Abstracts International $g 83-11B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29160959 $z click for full text (PQDT)